Rhumbline Advisers Royalty Pharma PLC Transaction History

Rhumbline Advisers

$113 Billion
Q2 2025

A detailed history of Rhumbline Advisers transactions in Royalty Pharma PLC stock. As of the latest transaction made, Rhumbline Advisers holds 447,240 shares of RPRX stock, worth $16.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

447,240

Previous 449,964 0.61%

Holding current value

$16.1 Million

Previous $14 Million 15.04%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$30.85 - $36.14 $84,035 - $98,445	-2,724 Reduced 0.61%	447,240 $16.1 Million
Q1 2025 Apr 08, 2025	SELL	$25.75 - $33.86 $107,738 - $141,670	-4,184 Reduced 0.92%	449,964 $14 Million
Q4 2024 May 29, 2025	BUY	$24.28 - $28.39 $101,587 - $118,783	4,184 Added 0.93%	454,148 $11.6 Million
Q4 2024 Jan 30, 2025	SELL	$24.28 - $28.39 $81,629 - $95,447	-3,362 Reduced 0.73%	454,148 $11.6 Million
Q3 2024 Nov 12, 2024	BUY	$25.63 - $29.27 $267,295 - $305,256	10,429 Added 2.33%	457,510 $12.9 Million
Q2 2024 Aug 01, 2024	SELL	$26.26 - $29.9 $293,192 - $333,833	-11,165 Reduced 2.44%	447,081 $11.8 Million
Q1 2024 May 09, 2024	BUY	$27.46 - $31.33 $68,375 - $78,011	2,490 Added 0.55%	458,246 $13.9 Million
Q4 2023 Feb 08, 2024	SELL	$26.21 - $29.22 $145,282 - $161,966	-5,543 Reduced 1.2%	455,756 $12.8 Million
Q3 2023 Nov 09, 2023	SELL	$26.26 - $31.38 $368,112 - $439,884	-14,018 Reduced 2.95%	461,299 $12.5 Million
Q2 2023 Aug 08, 2023	BUY	$29.6 - $36.56 $1.69 Million - $2.08 Million	57,011 Added 13.63%	475,317 $14.6 Million
Q1 2023 May 11, 2023	BUY	$32.77 - $39.4 $234,764 - $282,261	7,164 Added 1.74%	418,306 $15.1 Million
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $974,902 - $1.1 Million	24,889 Added 6.44%	411,142 $16.2 Million
Q3 2022 Nov 10, 2022	BUY	$39.88 - $44.65 $1.65 Million - $1.85 Million	41,475 Added 12.03%	386,253 $15.5 Million
Q2 2022 Aug 11, 2022	BUY	$37.53 - $44.22 $2.52 Million - $2.97 Million	67,171 Added 24.2%	344,778 $14.5 Million
Q1 2022 May 12, 2022	SELL	$37.46 - $42.44 $189,397 - $214,576	-5,056 Reduced 1.79%	277,607 $10.8 Million
Q4 2021 Feb 10, 2022	BUY	$35.17 - $42.48 $357,362 - $431,639	10,161 Added 3.73%	282,663 $11.3 Million
Q3 2021 Nov 12, 2021	SELL	$36.14 - $42.24 $605,489 - $707,688	-16,754 Reduced 5.79%	272,502 $9.85 Million
Q2 2021 Aug 05, 2021	SELL	$39.85 - $46.63 $300,747 - $351,916	-7,547 Reduced 2.54%	289,256 $11.9 Million
Q1 2021 May 06, 2021	BUY	$42.34 - $52.82 $8.44 Million - $10.5 Million	199,442 Added 204.85%	296,803 $12.9 Million
Q4 2020 Feb 10, 2021	BUY	$36.12 - $50.05 $743,783 - $1.03 Million	20,592 Added 26.82%	97,361 $4.87 Million
Q3 2020 Nov 12, 2020	BUY	$38.56 - $48.36 $2.96 Million - $3.71 Million	76,769 New	76,769 $3.23 Million

Others Institutions Holding RPRX

# of Institutions

495

Shares Held

306M

Call Options Held

1.99M

Put Options Held

384K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $15.7B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Royalty Pharma PLC Transaction History